Stock listing
Greenwich Lifesciences, Inc.
Selected listing: GLSI · NASDAQ · USD · US
Greenwich Lifesciences, Inc. (NASDAQ:GLSI), Health Technology. Latest release Aug 10, 2026: Greenwich LifeSciences Extends Lock-up of Directors and Officers…
- Ticker
- NASDAQ:GLSI
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Greenwich Lifesciences, Inc.
The company focuses on developing innovative therapies in the healthcare sector. As a publicly traded entity, it is subject to regulatory oversight and provides transparency to its investors.
Latest news from Greenwich Lifesciences, Inc.
Greenwich LifeSciences Extends Lock-up of Directors and Officers to January 31, 2027
August 10, 2026
Greenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom
July 22, 2026
Greenwich LifeSciences Provides Clinical Updates on FLAMINGO-01
July 20, 2026
Greenwich LifeSciences Announces European Approval for Combining Both HLA Populations in FLAMINGO-01
July 16, 2026
Greenwich LifeSciences Announces European Approval for Use of Commercially Manufactured GP2 in FLAMINGO-01
July 9, 2026
Research Greenwich Lifesciences, Inc.
Greenwich Lifesciences, Inc. company profile
View the public company page for Greenwich Lifesciences, Inc. on 6ix.
Greenwich Lifesciences, Inc. news
Read company news and market updates connected to Greenwich Lifesciences, Inc..
Greenwich Lifesciences, Inc. investor events
Find investor webinars, events, and replay context for Greenwich Lifesciences, Inc..